Skip to content
Low Dose GLP-1Providers

Provider review

Vaylen review

Every figure is written per month, and the footnote calls each one a year bought at once.

The site says monthly plans exist and prices none of them, so the plan a cautious reader would actually choose has no published figure.

Reviewed by Lena OrtizMetabolic Health Editor

Price updated August 2026

How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.

Price as published

Vaylen

From $83.25 sema, $149 tirz — each a 12-month prepay divided by 12

Vs median
Not comparable — no per-month rate is published — the verified string carries no monthly figure
Market
$59–$1300/mo across 242 of 373
Structure
Standard plan, self-directed low dose
Dispensed
Pharmacy not publicly identified

Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.

In one paragraph

The verdict

Vaylen prices well and publishes clearly, and a reader who skims will still come away with the wrong number in their head. The figures sit in the largest type on the page with a per-month suffix on each, and the dagger governing them is one line of small print saying each is the per-month cost of a twelve-month program billed upfront. That is a year of medication bought in a single charge. Divided by twelve it produces an attractive number; paid as advertised it is a substantial commitment made before a clinician has confirmed the treatment suits you. The refund promise takes some sting out of that — a full refund is stated if a clinician declines to prescribe — but it covers being turned down, not starting and stopping. The more useful sentence for anyone testing a small dose is the one immediately after: shorter programs and monthly plans are available. Those are exactly the plans a cautious reader wants, and not one of them carries a price anywhere on the site. So the pricing is precise about the option such a reader is least likely to choose and silent about the one they are most likely to choose. Nothing attaches a dose to any figure either, so even the annual arithmetic cannot be checked against an amount of drug. The medication, the prescription and the check-ins are stated to be inside the price rather than billed alongside it, and a needle-free daily tablet is sold beside the injectables.

Visit Vaylen

Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.

Who it suits, and who it does not

A good fit if

  • You have already decided to commit for a year and want the lowest annual figure
  • You want a needle-free daily tablet as an option rather than injections only
  • You want a stated refund if a clinician decides the treatment is not appropriate

Look elsewhere if

  • You want to pay by the month. Those plans are said to exist and none of them is priced
  • You are testing a small dose before committing. Every published figure assumes a year
  • You want to check a figure against an amount of drug. No dose is attached to any of them

What it actually costs

Price as published

No monthly rate is published. The banner, the hero and the plan grid all quote per-month figures — semaglutide from $83.25, tirzepatide from $149, oral semaglutide from $99 — and the dagger beneath the grid defines every one of them: "Price reflects the per-month cost of a 12-month program billed upfront, if prescribed." These are an annual total divided by twelve and payable only as a year · a separate "First month from $99" sits beside them, which is a first-month figure rather than a rate · the same footnote says "shorter programs and monthly plans available" and prices none of them, so the plan a reader would actually buy month to month has no published figure at all · no dose is attached to any figure · the plan is stated to include the prescription, the medication, provider check-ins and shipping with no membership underneath

Vs median
Not comparable — no per-month rate is published — the verified string carries no monthly figure
Market
$59–$1300/mo is the full published spread in our ranking
Structure
Standard plan, self-directed low dose

No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.

152 of the 373 programs we track price a small dose this way. Every per-month figure on the page is defined by the site's own footnote as the per-month cost of a twelve-month program billed upfront — a year bought in one charge and divided by twelve, not a rate anyone can pay monthly. The same footnote says monthly plans exist and prices none of them, so the plan a reader testing a low dose would actually buy has no published figure. No low-dose product is offered and no dose is attached to any figure. A needle-free daily tablet is sold alongside the injectables, which is a more forgiving vehicle for a small dose than drawing a partial unit.

Visit Vaylen

Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.

What is included

Consult
Included in the price
Dietitian
Not included
Labs
Optional
Pricing
Varies by dose, plan or tier
Price last updated
August 2026

What it does well

  • The footnote defines the pricing honestly instead of leaving the term implied.
  • The stated plan includes the medication, the prescription, check-ins and shipping.
  • A full refund is promised if a clinician decides treatment is not appropriate.

Pharmacy, labs and oversight

Vaylen does not publicly identify the pharmacy that fills its prescriptions. Bloodwork is offered but not required. A clinician review is included in the price.

Transparency check

1 of 4 published openly

What Vaylen publishes about itself, read from its own pages when we verified them — not estimated, and not a score.

Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
Not published
A price you can read before intakeThe figure appears only after an intake quiz, so it cannot be compared before signing up.
Not published
What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
Not published
No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
None on file

How the program works

Vaylen prices well and publishes clearly, and a reader who skims will still come away with the wrong number in their head. The figures are set in the largest type on the page with a per-month suffix on each one, and the dagger that governs them is a single line of small print under the grid saying that each is the per-month cost of a twelve-month program billed upfront. That is a year of medication bought in one charge. Divided by twelve it produces an attractive number; paid as advertised it is a four-figure commitment made before a clinician has confirmed the treatment suits you. The company's refund promise takes some of the sting out of that — it says plainly that a full refund follows if a clinician declines to prescribe — but the refund covers the case where you are turned down, not the case where you start and stop. For this site's reader the more useful sentence is the one that follows: shorter programs and monthly plans are available. Those are the plans a person testing a low dose would actually want, and not one of them carries a price anywhere on the site. So the published pricing is precise about the option a cautious reader is least likely to choose and silent about the one they are most likely to choose. Nothing on the page attaches a dose to any figure either, so even the annual arithmetic cannot be checked against an amount of drug. Clinical services are stated to run through OpenLoop Health, and the medication, the prescription and the check-ins are stated to be inside the price rather than billed alongside it.

The honest cons

Every headline figure is a year bought in one charge, divided by twelve.
  • The monthly plans the page says exist are not priced anywhere on the site.
  • No dose is attached to any figure, so none of it can be checked against a quantity.
Visit Vaylen

Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.

How it compares

Vaylen is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.

Where this sits

#225 of 373

Ordered with the companies that pay us first, and Vaylen is not one of them. A disclosed partition, not a score.

Compare all 373 providers →

Read this before you buy

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

Visit Vaylen

Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.

The closest alternative

RxSpan MD

From $194/mo

Vs median
$25/mo above the $169 median
Market
$59–$1300/mo across 242 of 373
Structure
Standard plan, self-directed low dose
Dispensed
Pharmacy not publicly identified

Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.

Read the RxSpan MD review →

Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.